A Randomized, Double-blind, Parallel Group Prospective Pilot Study to Assess the Effect of Vardenafil on Clinical Outcome and on Procedure Duration After Green Light Laser-ablation of the Prostate Gland for Therapy of Benign Prostate Hypertrophy (BPH)
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Vardenafil (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Bayer
- 27 Dec 2012 New source identified and integrated (German Clinical Trials Register: DRKS00004091).
- 03 Jun 2010 Secondary endpoint 'International Prostate Symptom Score' has not been met.
- 03 Jun 2010 Secondary endpoint 'Postvoid residual volume' has not been met.